HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prabhakar, S. Articles by Freedman, M. S. Search for Related Content PubMed PubMed Citation Articles by Prabhakar, S. Articles by Freedman, M. S.

Heat shock protein immunoreactivity in CSF

Correlation with oligoclonal banding and demyelinating disease

Department of Neurology (Dr. Prabhakar), CMC Hospital, Vellore, India; the Department of Neuroimmunology (Dr. Kurien and S. Zielinski), Montreal Neurological Institute, McGill University, Montreal, PQ, Canada; the Department of Biochemistry (Dr. Gupta), McMaster University, Hamilton, ON, Canada; and the Department of Medicine (Division of Neurology) (Dr. Freedman), Ottawa General Hospital, University of Ottawa, Ottawa, ON, Canada.

The detection of raised immunoglobulin and the presence of oligoclonal bands (OCBs) on electrophoresis of multiple sclerosis (MS) CSF has been a useful diagnostic test, but a universal antigen to which these MS antibodies are directed has yet to be found. Potentially immunogenic heat shock proteins (HSPs) are preferentially expressed in vitro in human oligodendrocytes compared with other glia, and in situ in oligodendrocytes found within the plaques of MS. Immunoreactivity directed against HSPs might therefore contribute to the immune-mediated demyelinating process found in MS. We examined this possibility by quantitatively (ELISA) measuring antibodies directed against a recombinant human HSP (HSP60) in CSF from 18 MS patients, and compared them with eight patients with acute disseminated encephalomyelitis, 12 with demyelinating peripheral neuropathies, and 59 with other neurologic diseases. Immunoblotting was used to confirm the specificity of the antibodies for binding to HSP60. We found a statistically significant correlation between antibody titers to HSP60 and the presence of OCBs in CSF. These results support the notion that HSP expression in the CNS, such as that observed in MS, may be immunogenic, leading to localized HSP antibody secretion. Such HSP-directed immunoreactivity could play a role in the pathogenesis of MS and other immune-mediated disorders of the nervous system.

Address correspondence and reprint requests to Dr. M.S. Freedman, University of Ottawa, Ottawa General Hospital, Division of Neurology, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada.

Supported in part by an operating grant from the Canadian Multiple Sclerosis Society (MSF).

Received December 8, 1993. Accepted in final form February 23, 1994.

This article has been cited by other articles:

				S. Tenembaum, N. Chamoles, and N. Fejerman Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients Neurology, October 22, 2002; 59(8): 1224 - 1231. [Abstract] [Full Text] [PDF]

				S.-Y. Yao, C. W. Stratton, W. M. Mitchell, and S. Sriram CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens Neurology, May 8, 2001; 56(9): 1168 - 1176. [Abstract] [Full Text] [PDF]